Physician profile
Michael B Burton
NPI 1760822423
$1,378.10
in general payments reported to CMS, 2019-2025
18 companies · $458 in 2025
The $458 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $15.63 · 2021: $133 · 2022: $94.16 · 2023: $272 · 2024: $282 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $286.52 | 2023-2025 | Azstarys |
| Depuy Synthes Sales INC. | $152.59 | 2025 | Conduit, Altalyne |
| Ironshore Pharmaceuticals INC. | $108.81 | 2023-2024 | Jornay Pm |
| Tris Pharma INC | $107.78 | 2021-2025 | Quillichew Er, Quillivant, Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $105.13 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $92.73 | 2019-2022 | |
| Cranial Technologies, INC | $85.46 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $76.59 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $73.51 | 2021-2023 | Qelbree |
| Adlon Therapeutics L.P. | $59.93 | 2020-2021 | |
| Vertical Pharmaceuticals, LLC | $45.32 | 2025 | Relexxii |
| Sobi, INC | $40.53 | 2019-2023 | |
| Pfizer INC. | $34.59 | 2022-2023 | |
| Glaxosmithkline, LLC. | $30.97 | 2022-2024 | Bexsero |
| Sanofi-Aventis U.S. LLC | $23.19 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19.57 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $18.21 | 2025 | Flucelvax |
| Neurelis, INC. | $16.67 | 2023 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.